[Federal Register Volume 59, Number 31 (Tuesday, February 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-3570]
[[Page Unknown]]
[Federal Register: February 15, 1994]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 123 and 1240
Food Safety Initiative; Notice of Public Meetings
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meetings.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration's (FDA) is announcing that it
is sponsoring nine public meetings that are intended to promote
understanding of FDA's recently announced food safety initiative. This
initiative includes the Food Code and the proposal to require that
domestic seafood processors, importers, and foreign processors who
export seafood to the United States establish hazard analysis critical
control point (HACCP) systems to ensure the safety of their products.
FDA is holding these meetings to facilitate informed public comment on
the seafood HACCP proposal.
DATES: For meeting dates, see Table 1 in ``Supplementary Information.''
ADDRESSES: For meeting addresses, see Table 1 in ``Supplementary
Information.''
FOR FURTHER INFORMATION CONTACT: Edward A. Steele (or the local
contact person listed in Table 2 in ``Supplementary Information''),
Office of Seafood, Center for Food Safety and Applied Nutrition (HFS-
405), Food and Drug Administration, 200 C St. SW., Washington, DC
20204, 202-254-3885.
SUPPLEMENTARY INFORMATION: FDA's food safety initiative was announced
by Donna E. Shalala, Secretary of Health and Human Services, on January
21, 1994. This initiative includes the proposal to require that
domestic seafood processors, importers, and foreign processors who
export seafood to the United States employ hazard analysis critical
control point (HACCP) systems in their processing of food to ensure the
safety of their products to consumers (59 FR 4142, January 28, 1994).
To promote understanding of the food safety initiative, FDA is
holding nine public meetings. At each meeting, the proposed HACCP
regulation will be explained, and time will be provided to answer
questions from the public about the proposal. By holding these public
meetings, the agency is hoping to facilitate the development of public
comments for consideration in the development of the HACCP final rule.
The purpose of these meetings is not, however, to receive comments.
The food safety initiative also includes the issuance of the Food
Code, which provides a model for those Federal, State, and local
jurisdictions that have regulatory responsibility for food service,
retail, and vending operations. The Food Code provides a framework for
the application of HACCP at the retail level. Agency personnel will be
present at these meetings to provide an overview of the Food Code.
The meetings will be held at the addresses and on the dates listed
in Table 1 as follows:
Table 1
------------------------------------------------------------------------
Meeting addresses Dates
------------------------------------------------------------------------
Stouffer Harbor Place Hotel, 202 East
Pratt St., Baltimore, MD
February 22, 1994
Wyndham Hamilton Hotel, 400 Park
Blvd., Itasca, IL
February 25, 1994
The LaGuardia Marriott, 102-05 Ditmars
Blvd., East Elmhurst, NY
March 2, 1994
Radisson Mart Plaza Hotel, 711 NW.,
72d Ave., Miami, FL
March 3, 1994
Westin Hotel, 100 Iberville St., New
Orleans, LA
March 4, 1994
Hyatt Regency Hotel, 6225 W. Century
Blvd., Los Angeles, CA
March 7, 1994
Seattle Center, Olympic Room, 305
Harrison St., Seattle, WA
March 8, 1994
Regal Alaskan Hotel, 4800 Stenard Rd.,
Anchorage, AK
March 10, 1994
The Hynes Convention Center, rm. 100, March 16, 1994
900 Boylston St., Boston, MA
------------------------------------------------------------------------
Meetings will be held from 1 p.m. to 4:30 p.m. Evening sessions,
which will be held from 7 p.m. to 8:30 p.m., are scheduled in all
cities, except Chicago (Itasca), Anchorage, and Boston. The evening
sessions in Baltimore, New York, Miami, New Orleans, Los Angeles, and
Seattle are being scheduled to accommodate those unable to attend the
afternoon sessions. Evening sessions will be limited to questions and
answers only.
There is no charge to attend these meetings. Advance registration
is requested. Early registration is suggested because space is limited.
The deadline for registering is 1 week before each meeting. Late
registration will be accepted pending availability of space. Those
persons interested in attending should fax their name, organization,
address, telephone number, and session of interest (afternoon or
evening) to the local contact persons listed in Table 2 as follows:
Table 2
------------------------------------------------------------------------
Meeting location Contact person
------------------------------------------------------------------------
Baltimore........................ Alexander A. Ondis, Baltimore
District Office, FDA, 900 Madison
Ave., Baltimore, MD 21201, 410-962-
3590 or FAX 410-962-2307.
Chicago.......................... Maxine Aubert, Chicago District
Office, FDA, 300 South Riverside
Plaza, suite 550 South, Chicago, IL
60606, 312-353-7379 or FAX 312-886-
3280.
New York......................... Joseph C. Famulare, New York
District, FDA, Long Island Resident
Post, 6800 Jericho Turnpike, suite
109E, Syosset, New York 11791, 516-
921-2869 or FAX 516-921-3025.
Miami............................ Lynne C. Issacs, Orlando District
Office, FDA, 7200 Lake Ellenor Dr.,
suite 120, Orlando, FL 32809, 407-
648-6922 or FAX 407-648-6221.
New Orleans...................... Tura King, New Orleans District
Office, FDA, 4298 Elysian Fields,
New Orleans, LA 70122, 504-589-4334
or FAX 504-589-4365.
Los Angeles...................... Yvonne Banegas, Los Angeles District
Office, FDA, 1521 West Pico Blvd.,
Los Angeles, CA 90015, 213-252-7586
or FAX 213-251-7148.
Seattle.......................... Sue Hutchcroft, Seattle District
Office, FDA, 22201 23d Dr. SE.,
Bothell, WA 98041, 206-483-4999 or
FAX 206-483-4996.
Anchorage........................ Sue Hutchcroft, Seattle District
Office, FDA, 22201 23d Dr. SE.,
Bothell, WA 98041, 206-483-4999 or
FAX 206-483-4996.
Boston........................... Alyson L. Saben, Boston District
Office, FDA, One Montvale Ave.,
Stoneham, MA 02180, 617-279-1675,
ext. 118 or FAX 617-279-1742.
------------------------------------------------------------------------
Dated: February 10, 1994.
Michael R. Taylor,
Deputy Commissioner for Policy.
[FR Doc. 94-3570 Filed 2-11-94; 9:37 am]
BILLING CODE 4160-01-F
